314 related articles for article (PubMed ID: 31196219)
1. Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling.
Marijt KA; Sluijter M; Blijleven L; Tolmeijer SH; Scheeren FA; van der Burg SH; van Hall T
J Immunother Cancer; 2019 Jun; 7(1):152. PubMed ID: 31196219
[TBL] [Abstract][Full Text] [Related]
2. Microenvironmental stresses induce HLA-E/Qa-1 surface expression and thereby reduce CD8(+) T-cell recognition of stressed cells.
Sasaki T; Kanaseki T; Shionoya Y; Tokita S; Miyamoto S; Saka E; Kochin V; Takasawa A; Hirohashi Y; Tamura Y; Miyazaki A; Torigoe T; Hiratsuka H; Sato N
Eur J Immunol; 2016 Apr; 46(4):929-40. PubMed ID: 26711740
[TBL] [Abstract][Full Text] [Related]
3. STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients.
Srivastava RM; Trivedi S; Concha-Benavente F; Hyun-Bae J; Wang L; Seethala RR; Branstetter BF; Ferrone S; Ferris RL
Cancer Immunol Res; 2015 Aug; 3(8):936-45. PubMed ID: 25972070
[TBL] [Abstract][Full Text] [Related]
4. Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression.
Chandrasekaran S; Sasaki M; Scharer CD; Kissick HT; Patterson DG; Magliocca KR; Seykora JT; Sapkota B; Gutman DA; Cooper LA; Lesinski GB; Waller EK; Thomas SN; Kotenko SV; Boss JM; Moreno CS; Swerlick RA; Pollack BP
Mol Cancer Res; 2019 Dec; 17(12):2395-2409. PubMed ID: 31548239
[TBL] [Abstract][Full Text] [Related]
5. Metastatic melanoma cells evade immune detection by silencing STAT1.
Osborn JL; Greer SF
Int J Mol Sci; 2015 Feb; 16(2):4343-61. PubMed ID: 25690042
[TBL] [Abstract][Full Text] [Related]
6. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
7. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
Yin W; Song Y; Liu Q; Wu Y; He R
Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
[TBL] [Abstract][Full Text] [Related]
8. Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines.
Respa A; Bukur J; Ferrone S; Pawelec G; Zhao Y; Wang E; Marincola FM; Seliger B
Clin Cancer Res; 2011 May; 17(9):2668-78. PubMed ID: 21248298
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells.
Liang YH; Chen KH; Tsai JH; Cheng YM; Lee CC; Kao CH; Chan KY; Chen YT; Hsu WL; Yeh KH
J Biomed Sci; 2021 Nov; 28(1):75. PubMed ID: 34758826
[TBL] [Abstract][Full Text] [Related]
10. Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line.
Dovhey SE; Ghosh NS; Wright KL
Cancer Res; 2000 Oct; 60(20):5789-96. PubMed ID: 11059775
[TBL] [Abstract][Full Text] [Related]
11. Francisella inhibits STAT1-mediated signaling in macrophages and prevents activation of antigen-specific T cells.
Roth KM; Gunn JS; Lafuse W; Satoskar AR
Int Immunol; 2009 Jan; 21(1):19-28. PubMed ID: 19001470
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma-induced MHC class I expression and defects in Jak/Stat signalling in methylcholanthrene-induced sarcomas.
Svane IM; Engel AM; Nielsen M; Werdelin O
Scand J Immunol; 1997 Oct; 46(4):379-87. PubMed ID: 9350289
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation.
Zhou F
Int Rev Immunol; 2009; 28(3-4):239-60. PubMed ID: 19811323
[TBL] [Abstract][Full Text] [Related]
15. Cancer/testis Antigen MAGEA3 Interacts with STAT1 and Remodels the Tumor Microenvironment.
Wang Y; Song X; Zheng Y; Liu Z; Li Y; Qian X; Pang X; Zhang Y; Yin Y
Int J Med Sci; 2018; 15(14):1702-1712. PubMed ID: 30588194
[TBL] [Abstract][Full Text] [Related]
16. IFNgammaR2 trafficking tunes IFNgamma-STAT1 signaling in T lymphocytes.
Regis G; Conti L; Boselli D; Novelli F
Trends Immunol; 2006 Feb; 27(2):96-101. PubMed ID: 16380292
[TBL] [Abstract][Full Text] [Related]
17. Activation and potentiation of interferon-gamma signaling by 3,3'-diindolylmethane in MCF-7 breast cancer cells.
Riby JE; Xue L; Chatterji U; Bjeldanes EL; Firestone GL; Bjeldanes LF
Mol Pharmacol; 2006 Feb; 69(2):430-9. PubMed ID: 16267208
[TBL] [Abstract][Full Text] [Related]
18. Catch and Release of Cytokines Mediated by Tumor Phosphatidylserine Converts Transient Exposure into Long-Lived Inflammation.
Oyler-Yaniv J; Oyler-Yaniv A; Shakiba M; Min NK; Chen YH; Cheng SY; Krichevsky O; Altan-Bonnet N; Altan-Bonnet G
Mol Cell; 2017 Jun; 66(5):635-647.e7. PubMed ID: 28575659
[TBL] [Abstract][Full Text] [Related]
19. LATS1/2 loss promote tumor immune evasion in endometrial cancer through downregulating MHC-I expression.
Yang Q; Lv Z; Wang M; Kong M; Zhong C; Gao K; Wan X
J Exp Clin Cancer Res; 2024 Feb; 43(1):54. PubMed ID: 38383447
[TBL] [Abstract][Full Text] [Related]
20. High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway.
Duan Q; Li H; Gao C; Zhao H; Wu S; Wu H; Wang C; Shen Q; Yin T
J Exp Clin Cancer Res; 2019 May; 38(1):192. PubMed ID: 31088566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
